LYKALABSNSELyka Labs Limited· PharmaceuticalsMediumNeutral
Announced Wed, 2 Apr · 18:26 IST

Lyka Labs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lyka Labs Limited has filed a disclosure with the stock exchange as required under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This is a routine yearly compliance submission by persons holding 5% or more shares in the company, reporting their shareholding and voting rights as of the financial year end. The announcement itself does not provide specific details on any changes in shareholding, pledges, or stake movements.

Likely market impact

This is a standard regulatory filing and is unlikely to have any immediate impact on the stock price. Investors should review the actual disclosure details separately to check for any changes in promoter or major shareholder holdings.